281 related articles for article (PubMed ID: 27184103)
1. Discovery of a novel covalent non-β-lactam inhibitor of the metallo-β-lactamase NDM-1.
Christopeit T; Albert A; Leiros HS
Bioorg Med Chem; 2016 Jul; 24(13):2947-2953. PubMed ID: 27184103
[TBL] [Abstract][Full Text] [Related]
2. Fragment-based discovery of inhibitor scaffolds targeting the metallo-β-lactamases NDM-1 and VIM-2.
Christopeit T; Leiros HK
Bioorg Med Chem Lett; 2016 Apr; 26(8):1973-7. PubMed ID: 26976213
[TBL] [Abstract][Full Text] [Related]
3. Structure-guided optimization of D-captopril for discovery of potent NDM-1 inhibitors.
Ma G; Wang S; Wu K; Zhang W; Ahmad A; Hao Q; Lei X; Zhang H
Bioorg Med Chem; 2021 Jan; 29():115902. PubMed ID: 33302045
[TBL] [Abstract][Full Text] [Related]
4. Ebselen as a potent covalent inhibitor of New Delhi metallo-β-lactamase (NDM-1).
Chiou J; Wan S; Chan KF; So PK; He D; Chan EW; Chan TH; Wong KY; Tao J; Chen S
Chem Commun (Camb); 2015 Jun; 51(46):9543-6. PubMed ID: 25970101
[TBL] [Abstract][Full Text] [Related]
5. Efforts towards the inhibitor design for New Delhi metallo-beta-lactamase (NDM-1).
Nagulapalli Venkata KC; Ellebrecht M; Tripathi SK
Eur J Med Chem; 2021 Dec; 225():113747. PubMed ID: 34391033
[TBL] [Abstract][Full Text] [Related]
6. Synthesis and biological evaluation of Aspergillomarasmine A derivatives as novel NDM-1 inhibitor to overcome antibiotics resistance.
Zhang J; Wang S; Wei Q; Guo Q; Bai Y; Yang S; Song F; Zhang L; Lei X
Bioorg Med Chem; 2017 Oct; 25(19):5133-5141. PubMed ID: 28784300
[TBL] [Abstract][Full Text] [Related]
7. Risedronate and Methotrexate Are High-Affinity Inhibitors of New Delhi Metallo-β-Lactamase-1 (NDM-1): A Drug Repurposing Approach.
Muteeb G; Alsultan A; Farhan M; Aatif M
Molecules; 2022 Feb; 27(4):. PubMed ID: 35209073
[TBL] [Abstract][Full Text] [Related]
8. High-Throughput Virtual Screening, Molecular Dynamics Simulation, and Enzyme Kinetics Identified ZINC84525623 as a Potential Inhibitor of NDM-1.
Rehman MT; AlAjmi MF; Hussain A; Rather GM; Khan MA
Int J Mol Sci; 2019 Feb; 20(4):. PubMed ID: 30769822
[TBL] [Abstract][Full Text] [Related]
9. A protein structure-guided covalent scaffold selectively targets the B1 and B2 subclass metallo-β-lactamases.
Chen C; Xiang Y; Yang KW; Zhang Y; Wang WM; Su JP; Ge Y; Liu Y
Chem Commun (Camb); 2018 May; 54(38):4802-4805. PubMed ID: 29687124
[TBL] [Abstract][Full Text] [Related]
10. Probing the mechanisms of inhibition for various inhibitors of metallo-β-lactamases VIM-2 and NDM-1.
Thomas CA; Cheng Z; Yang K; Hellwarth E; Yurkiewicz CJ; Baxter FM; Fullington SA; Klinsky SA; Otto JL; Chen AY; Cohen SM; Crowder MW
J Inorg Biochem; 2020 Sep; 210():111123. PubMed ID: 32622213
[TBL] [Abstract][Full Text] [Related]
11. Probing the Interaction of Aspergillomarasmine A with Metallo-β-lactamases NDM-1, VIM-2, and IMP-7.
Bergstrom A; Katko A; Adkins Z; Hill J; Cheng Z; Burnett M; Yang H; Aitha M; Mehaffey MR; Brodbelt JS; Tehrani KHME; Martin NI; Bonomo RA; Page RC; Tierney DL; Fast W; Wright GD; Crowder MW
ACS Infect Dis; 2018 Feb; 4(2):135-145. PubMed ID: 29091730
[TBL] [Abstract][Full Text] [Related]
12. Captopril analogues as metallo-β-lactamase inhibitors.
Yusof Y; Tan DTC; Arjomandi OK; Schenk G; McGeary RP
Bioorg Med Chem Lett; 2016 Mar; 26(6):1589-1593. PubMed ID: 26883147
[TBL] [Abstract][Full Text] [Related]
13. Inhibitor discovery of full-length New Delhi metallo-β-lactamase-1 (NDM-1).
Shen B; Yu Y; Chen H; Cao X; Lao X; Fang Y; Shi Y; Chen J; Zheng H
PLoS One; 2013; 8(5):e62955. PubMed ID: 23675445
[TBL] [Abstract][Full Text] [Related]
14. Ten Years with New Delhi Metallo-β-lactamase-1 (NDM-1): From Structural Insights to Inhibitor Design.
Linciano P; Cendron L; Gianquinto E; Spyrakis F; Tondi D
ACS Infect Dis; 2019 Jan; 5(1):9-34. PubMed ID: 30421910
[TBL] [Abstract][Full Text] [Related]
15. Covalent inhibition of New Delhi metallo-β-lactamase-1 (NDM-1) by cefaclor.
Thomas PW; Cammarata M; Brodbelt JS; Fast W
Chembiochem; 2014 Nov; 15(17):2541-8. PubMed ID: 25302694
[TBL] [Abstract][Full Text] [Related]
16. Novel non-β-lactam inhibitor of β-lactamase TEM-171 based on acylated phenoxyaniline.
Grigorenko VG; Andreeva IP; Rubtsova MY; Deygen IM; Antipin RL; Majouga AG; Egorov AM; Beshnova DA; Kallio J; Hackenberg C; Lamzin VS
Biochimie; 2017 Jan; 132():45-53. PubMed ID: 27771370
[TBL] [Abstract][Full Text] [Related]
17. A Lysine-Targeted Affinity Label for Serine-β-Lactamase Also Covalently Modifies New Delhi Metallo-β-lactamase-1 (NDM-1).
Thomas PW; Cammarata M; Brodbelt JS; Monzingo AF; Pratt RF; Fast W
Biochemistry; 2019 Jun; 58(25):2834-2843. PubMed ID: 31145588
[TBL] [Abstract][Full Text] [Related]
18. Discovery of the Novel Inhibitor Against New Delhi Metallo-β-Lactamase Based on Virtual Screening and Molecular Modelling.
Wang X; Yang Y; Gao Y; Niu X
Int J Mol Sci; 2020 May; 21(10):. PubMed ID: 32443639
[TBL] [Abstract][Full Text] [Related]
19. Non-active site mutation (Q123A) in New Delhi metallo-β-lactamase (NDM-1) enhanced its enzyme activity.
Ali A; Azam MW; Khan AU
Int J Biol Macromol; 2018 Jun; 112():1272-1277. PubMed ID: 29454953
[TBL] [Abstract][Full Text] [Related]
20. Discovery of Novel Inhibitor Scaffolds against the Metallo-β-lactamase VIM-2 by Surface Plasmon Resonance (SPR) Based Fragment Screening.
Christopeit T; Carlsen TJ; Helland R; Leiros HK
J Med Chem; 2015 Nov; 58(21):8671-82. PubMed ID: 26477515
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
